125 related articles for article (PubMed ID: 31027698)
1. Advanced NSCLC patients with high IL-6 levels have altered peripheral T cell population and signaling.
Rice SJ; Liu X; Zhang J; Jia B; Zheng H; Belani CP
Lung Cancer; 2019 May; 131():58-61. PubMed ID: 31027698
[TBL] [Abstract][Full Text] [Related]
2. Disturbed Th17/Treg Balance in Patients with Non-small Cell Lung Cancer.
Duan MC; Han W; Jin PW; Wei YP; Wei Q; Zhang LM; Li JC
Inflammation; 2015 Dec; 38(6):2156-65. PubMed ID: 26077695
[TBL] [Abstract][Full Text] [Related]
3. Elevated Circulating CD4
Hu X; Gu Y; Zhao S; Hua S; Jiang Y
Cancer Biother Radiopharm; 2019 Jun; 34(5):325-333. PubMed ID: 30925076
[No Abstract] [Full Text] [Related]
4. Correlation between the Treg/Thl7 Index and the Efficacy of PD-1 Monoclonal Antibody in Patients with Advanced Non-Small-Cell Lung Cancer Complicated with Chronic Obstructive Pulmonary Disease.
Wang X; She X; Gao W; Liu X; Shi B
Comput Math Methods Med; 2022; 2022():2923998. PubMed ID: 35915772
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy.
Liu C; Wu S; Meng X; Liu G; Chen D; Cong Y; Shen G; Sun B; Wang W; Wang Q; Gao H; Liu X
Oncotarget; 2017 Jun; 8(26):43427-43438. PubMed ID: 28624781
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 8 in plasma is an efficacy marker for advanced non-small cell lung cancer treated with hypofractionated radiotherapy and PD-1 blockade.
Kang P; Liu D; Li L; Guo X; Ye Y; Li Y; Jiang Q; Lin S; Yuan Q
Cytokine; 2023 Mar; 163():156133. PubMed ID: 36724715
[TBL] [Abstract][Full Text] [Related]
7. Expression of PD1 and BTLA on the CD8
Bao Y; Mo JF; Wu JY; Cao CX
Chin Med Sci J; 2019 Nov; 34(4):248-255. PubMed ID: 33906710
[No Abstract] [Full Text] [Related]
8. Clinical significance of expanded Foxp3⁺ Helios⁻ regulatory T cells in patients with non-small cell lung cancer.
Muto S; Owada Y; Inoue T; Watanabe Y; Yamaura T; Fukuhara M; Okabe N; Matsumura Y; Hasegawa T; Osugi J; Hoshino M; Higuchi M; Suzuki H; Gotoh M
Int J Oncol; 2015 Dec; 47(6):2082-90. PubMed ID: 26460798
[TBL] [Abstract][Full Text] [Related]
9. Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints.
Fiocco U; Martini V; Accordi B; Caso F; Costa L; Oliviero F; Scanu A; Felicetti M; Frallonardo P; Facco M; Boso D; Molena B; Zambello R; Ramonda R; Cozzi F; Scarpa R; Basso G; Semenzato G; Dayer JM; Doria A; Punzi L
J Rheumatol Suppl; 2015 Nov; 93():48-52. PubMed ID: 26523057
[TBL] [Abstract][Full Text] [Related]
10. MiR-21 Participates in the PD-1/PD-L1 Pathway-Mediated Imbalance of Th17/Treg Cells in Patients After Gastric Cancer Resection.
Zheng X; Dong L; Wang K; Zou H; Zhao S; Wang Y; Wang G
Ann Surg Oncol; 2019 Mar; 26(3):884-893. PubMed ID: 30565043
[TBL] [Abstract][Full Text] [Related]
11. Analyzing the percentage of different PD-1
Hu X; Gu Y; Li D; Zhao S; Hua S; Jiang Y
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1074-1083. PubMed ID: 31381177
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patients.
Kotsakis A; Koinis F; Katsarou A; Gioulbasani M; Aggouraki D; Kentepozidis N; Georgoulias V; Vetsika EK
Sci Rep; 2016 Dec; 6():39247. PubMed ID: 27976733
[TBL] [Abstract][Full Text] [Related]
13. The potential predictive value of circulating immune cell ratio and tumor marker in atezolizumab treated advanced non-small cell lung cancer patients.
Zhuo M; Chen H; Zhang T; Yang X; Zhong J; Wang Y; An T; Wu M; Wang Z; Huang J; Zhao J
Cancer Biomark; 2018; 22(3):467-476. PubMed ID: 29758930
[TBL] [Abstract][Full Text] [Related]
14. Long-term prognostic significance of interleukin-17-producing T cells in patients with non-small cell lung cancer.
Song L; Ma S; Chen L; Miao L; Tao M; Liu H
Cancer Sci; 2019 Jul; 110(7):2100-2109. PubMed ID: 31100180
[TBL] [Abstract][Full Text] [Related]
15. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
16. Immune Microenvironment Differences Between Squamous and Non-squamous Non-small-cell Lung Cancer and Their Influence on the Prognosis.
Meng X; Gao Y; Yang L; Jing H; Teng F; Huang Z; Xing L
Clin Lung Cancer; 2019 Jan; 20(1):48-58. PubMed ID: 30341017
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation.
Chen N; Fang W; Zhan J; Hong S; Tang Y; Kang S; Zhang Y; He X; Zhou T; Qin T; Huang Y; Yi X; Zhang L
J Thorac Oncol; 2015 Jun; 10(6):910-23. PubMed ID: 25658629
[TBL] [Abstract][Full Text] [Related]
18. Expression of PD-1 on CD4+ T cells in peripheral blood associates with poor clinical outcome in non-small cell lung cancer.
Zheng H; Liu X; Zhang J; Rice SJ; Wagman M; Kong Y; Zhu L; Zhu J; Joshi M; Belani CP
Oncotarget; 2016 Aug; 7(35):56233-56240. PubMed ID: 27191652
[TBL] [Abstract][Full Text] [Related]
19. The Role of Circulating T Follicular Helper Cells and Regulatory Cells in Non-Small Cell Lung Cancer Patients.
Guo Z; Liang H; Xu Y; Liu L; Ren X; Zhang S; Wei S; Xu P
Scand J Immunol; 2017 Aug; 86(2):107-112. PubMed ID: 28513867
[TBL] [Abstract][Full Text] [Related]
20. Variation of blood T lymphocyte subgroups in patients with non- small cell lung cancer.
Wang WJ; Tao Z; Gu W; Sun LH
Asian Pac J Cancer Prev; 2013; 14(8):4671-3. PubMed ID: 24083723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
